Work

Early CTC decline as a biomarker of response to treatment in castration-resistant prostate cancer (CRPC): Analysis of the COU-AA-301 and IMMC38 trials.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.5014

Authors: David Lorente, David Olmos, Joaquin Mateo, Diletta Bianchini, George Seed, Penelope Flohr, Mateus Crespo, Ines Figueiredo, Susana Miranda, Kurt Baeten, Tim Pitfield, Arturo Molina, Thian Kheoh, Robert Thomas Mccormack, Howard I. Scher, Johann Sebastian De Bono

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Spanish National Cancer Research Centre, Janssen (Belgium), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2893346630

Cites:

Cited by: 6

Related to: 10